|
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
RECRUITINGPhase 2Sponsored by Bristol-Myers Squibb
Actively Recruiting
PhasePhase 2
SponsorBristol-Myers Squibb
Started2023-11-07
Est. completion2026-07-03
Eligibility
Age40 Years – 85 Years
Healthy vol.Accepted
Locations31 sites
View on ClinicalTrials.gov →
NCT06122779
Summary
The purpose of this study is to evaluate the safety, tolerability, and exposure-response (E-R) of BMS-986435/MYK-224 in participants with symptomatic Heart Failure with Preserved Ejection Fraction (HFpEF).
Eligibility
Age: 40 Years – 85 YearsHealthy volunteers accepted
Inclusion Criteria \- Adult participants with stable, symptomatic HFpEF with a normal heart pumping ability. Exclusion Criteria * Participants must not have a known diagnosis of obstructive or genetic hypertrophic cardiomyopathy or infiltrative/storage disorder such as cardiac amyloidosis, or any other acute or serious condition that could interfere with assessments during the study or may pose a risk to the participant. * Other protocol-defined Inclusion/Exclusion criteria apply.
Conditions2
Heart DiseaseHeart Failure
Interventions1
Locations31 sites
University of Alabama at Birmingham
Birmingham, Alabama, 35233
Pankaj Arora, Site 0002
Colorado Heart and Vascular - Lakewood
McHale Anderson, Site 0096303-595-2619
Ascension St. Vincent's Riverside Hospital - PPDS
Nima Taghipour, Site 0077888-888-8888
Find trials near these locations
Heart Disease trials in JacksonvilleHeart Disease trials in MiamiHeart Disease trials in AtlantaHeart Disease trials in ChicagoHeart Disease trials in IndianapolisHeart Disease trials in New YorkHeart Disease trials in Oklahoma CityHeart Disease trials in AustinHeart Disease trials in DallasHeart Disease trials in HoustonAll trials in ColoradoAll trials in FloridaAll trials in GeorgiaAll trials in IllinoisAll trials in IndianaAll trials in MissouriAll trials in New YorkAll trials in North CarolinaAll trials in OhioAll trials in OklahomaAll trials in PennsylvaniaAll trials in TennesseeAll trials in TexasAll trials in Virginia
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 2
SponsorBristol-Myers Squibb
Started2023-11-07
Est. completion2026-07-03
Eligibility
Age40 Years – 85 Years
Healthy vol.Accepted
Locations31 sites
View on ClinicalTrials.gov →
NCT06122779